Neuropharmacology of Lithium By: Kathryn Carson, Brandon LeBlanc, Daniel Greco, Ashour Barkho PHM142 Fall 2015 Instructor: Dr. Jeffrey Henderson.

Slides:



Advertisements
Similar presentations
Lithium Toxicity Robert Nashat, Pharm.D, CDE Medical Place Pharmacy 20 Emma St, Chatham, On.
Advertisements

Problems do not go away. They must be worked through or else they remain, forever a barrier… M. Scott Peck.
Drugs Used During Pregnancy & Lactation
2003 August Dar Al-Ajaza Al-Islamia Hospital in Beirut1 Bipolar Disorder An Update Presented by Dr Ismail Habli Moderator: Dr Elio Sassine.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
IzBen C. Williams, MD, MPH Instructor. Lecture - 11 MOOD DISORDERS.
Bipolar Disorder and Diet Kristin Schefcik. What is bipolar disorder? Mania Euphoric mood Increased energy Decreased need for sleep Rapid thinking and.
CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology Dr. Robert L. Patrick Department of Neuroscience Brown University Biomed.
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner.
2007. Statistics  2-4 new cases per 100,000/year  1 in 200 people will have an episode of hypomania  Peak age of onset yrs  May have had a previous.
Bipolar Disorder For BIO 443: Drugs and Disease Presented by: Abby Normal.
Drugs for Bipolar Disorders Kaukab Azim, MBBS, PhD.
Manic Depression By Jason Li + Seth Horan.
Bipolar Disorders.
By the end of this lecture you will be able to: Recognize the possible causes in mood swing in bipolar depression Classify mood stabilizing drugs Focus.
Chapter Fifteen Alcoholism, Mood Disorders, and Schizophrenia.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 33 Drugs for Bipolar Disorder.
Types of Treatment.
Control of Energy The Original Biofuels. Importance of Glucose Regulation Too little – Brain problems Too much –Osmotic water loss (cellular and systemic)
Chapter 13 Bipolar and Related Disorders Copyright © 2014, 2010, 2006 by Saunders, an imprint of Elsevier Inc.
Affective and Anxiety Disorders. What are affective disorders? Disorders of mood found throughout history unipolar or major depression bipolar or manic.
Management of Bipolar Affective Disorders
Anti-manic drugs.
Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.
What Therapies Are Used to Treat Psychological Problems?
IzBen C. Williams, MD, MPH Instructor. Lecture - 8 MOOD DISORDERS.
Regulation of insulin levels Starter: what do each of the following cells produce and are they part of the endocrine or exocrine system; –α cells –β cells.
By the end of this lecture you will be able to: Recognize the possible causes in mood swing in bipolar depression Classify mood stabilizing drugs Focus.
Introduction to the Biological Basis for Understanding Psychotropic Drugs.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 16Psychopharmacology.
Chapter Fifteen Alcoholism, Mood Disorders, and Schizophrenia.
Bipolar Disorder BY DR ABIODUN MARK AKANMODE.. Bipolar disorder, also known as manic depression, is a psychiatric diagnosis that describes a category.
Rivastigmine Tartrate Presented by: Mona Abdulrahman Alkallabi Mona Abdulrahman Alkallabi.
Drugs for Bipolar Disorders Kaukab Azim, MBBS, PhD.
Treatment Resistant Pediatric BD Elham Shirazi M.D. Board of General Psychiatry Board of Child & Adolescent Psychiatry.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
Mitochondria in the etiology and pathogenesis of Parkinson's disease
The Neurochemistry of Friedreich’s Ataxia By: Michelle Donnelly, Virginia Gamero, Vinson Li, and Pooja Maharajh PHM142 Fall 2015 Coordinator: Dr. Jeffrey.
MOOD DISORDERS 2 Dr Nesif J. Al-Hemiary MBChB - FICMS(Psych) International Associate of the RCPsych.(UK) International Associate of the RCPsych.(UK)
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05Psychopharmacology.
For MHD & Therapeutics is proud to present And Now Here Is The Host... Dr. Schilling.
Donepezil. Donepezil Generic name: Donepezil. Brand name: Aricept. Chemistry: Donepezil hydrochloride is a piperidine derivative. It is a white crystalline.
Drugs for Bipolar Disorder. Bipolar Disorder  Formerly known as manic-depressive illness  Afflicts an estimated 3.7% of the adult population  Mainstays.
PHARMACOLOGY TUTORING FOR ANTIDEPRESSANTS By Alaina Darby.
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Trazodone  Trazodone is a second line agent for treatment of depression. Antidepressant effects take several weeks to develop.Trazodone produces selective.
INTRODUCTORY MENTAL HEALTH NURSING Donna M. Womble 2005.
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
Lithium Practical Prescribing
Life Span Consideration
Drugs for Bipolar Disorders
Drugs for Bipolar Disorder
Lithium: Clinical Uses and Pharmacokinetics
Introduction to bipolar disorder
Basic pharmacology of lithium
Other drugs used in the treatment of bipolar disorder
Bipolar Depression Pharmacotherapy: Part 1
BIPOLAR DISORDER Insert name of instructor, title, and contact information.
Introduction; Scope of Pharmacology Routes of Drug Administration
Cell Signaling.
Neurobiology of MDD for Social and Physical Stress
Pharmacokinetics and Factors of Individual Variation
Valproate MOA and Clinical Uses
Lithium: Mechanism of Action
Basic Biopharmaceutics
The Challenges of Bipolar Disorders
Module 3 Indications for Antipsychotics Bipolar Disorder
Presentation transcript:

Neuropharmacology of Lithium By: Kathryn Carson, Brandon LeBlanc, Daniel Greco, Ashour Barkho PHM142 Fall 2015 Instructor: Dr. Jeffrey Henderson

What is Lithium?  Monovalent cation  Competes for monovalent/divalent cellular sites  Often sites involved in the synthesis, storage, release and reuptake of neurotransmitters (NTs)  Ex. alters Na + transport in neurons  Drug Class: antimanic – mood stabilizer  Non-pharmacological use = lithium batteries

What is it used for? Indications: Health Canada Approved  Management of acute manic episodes  Maintenance treatment of bipolar disorder Off-Label Uses Augmentation therapy in patients with treatment-resistant depression Prophylactic management of chronic cluster headaches

Formulations Lithium carbonate  Extended release tablet  Immediate release capsule Lithium citrate Syrup Oral Administration  Well absorbed from the GI tract  Crosses the blood brain barrier (BBB)  Css reached within 4 days  Full effect may take days following initiation of therapy

What exactly is Bipolar Disorder? Bipolar disorder is a complex, recurrent mood disorder Formerly called manic depression Patients experience manic episodes and major depressive episodes Affects 1-2% of the population Patients experience reocurring episodes: Manic episodes Major depressive episodes

Clinical Role of Lithium Lithium is a first line treatment for bipolar disorder Exerts its effects primarily on manic episodes Functions to manage deppresive episodes In Canada Lithium is sold under the brand names Carbolith, Lithmax, Lithane, Duralith Goals for therapy: Control symptoms of episodes Prevent reoccurence

Important Considerations Lithium has a very narrow therapeutic window Patients must be monitored regularly while on treatment Lithium is a teratogen Capable of passing the placenta and present in breast milk Causes heart defects in developing fetus Primarily excreted renally Issues arise when renal function is impaired

Mechanism of Action Many hypothesized mechanisms: -Telomere shortening prevention, increased mitochondrial function, and regulation of circadian rhythm. Li + and Mg 2+ competition: -Diagonal relationship. -Electronegativity and atomic radii. Mota de Freitas, D., et al, Acc. Chem. Res., 39, 2006,

Li + competition of Mg 2+ Glycogen synthase kinase 3β: -Inhibition promotes neuroprotection. -GSK-3β is pro-apoptotic. Interest: Pharmacological inhibition led to anti-manic and anti-depressant effects. Chuang, D-M. et al, Frontiers in Mol. Neuroscience, 4(15), 2011, 1-12 Mota de Freitas, D., et al, Acc. Chem. Res., 39, 2006,

Li + competition with Mg 2+ IMPase and IPPase: -Inhibition reduces inositol levels. -Decreased Ca 2+ release. -Increased expression in the cerebellum. -Inositol transporter found to be overexpressed in BD. Mota de Freitas, D., et al, Acc. Chem. Res., 39, 2006, Alda, M., Molecular Psychiatry, 20, 2015, Harwood, A.J., Molecular Psychiatry, 10, 2005,

Li + competition of Mg 2+ Adenylyl Cyclase: -Inhibition decreases production of cAMP. -Individuals with BP show increased G sα and cAMP in the cerebral cortex. Interest: Addition of Mg 2+ reverses effects of Li +. Zimmerman, G., et al, J. Biol. Chem., 273(31), 1998, Mota de Freitas, D., et al, Acc. Chem. Res., 39, 2006, Alda, M., Molecular Psychiatry, 20, 2015,

Current Difficulties Lithium Treatment for Bipolar disorder 1 st line treatment Lack of Compliance Discontinuation can be fatal Anticonvulsant Drugs Valproate, gabapentin More effective for “kindlers”

Future Treatments Signal Transduction Control mood by targeting specific enzymes Future research on pathophysiology Genetics Gene manipulation Eliminate factors causing the illness

Summary Slide Belongs to the drug class: antimanic – acts as a mood stabilizer. Is approved by health canada for the treatment of acute manic episodes and as maintenance therapy of bipolar disorder. Is administered orally either as: lithium carbonate or lithium citrate. Lithium has a narrow therapeutic window. Mechanism of action not fully understood, but competition with Mg 2+ viable option. Current Lithium treatment for Bipolar disorder causes hand tremors, weight gain, cognitive impaired function. Gene manipulation and targeting enzymes in signal transduction pathway are future methods to treat bipolar disorder.